Special notice
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
FDABAA-27-00123
Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
February 1, 2027 at 5:00 PM EST
Closed in 93 days. Posted October 30, 2026, first published October 30, 2026. Scheduled to archive February 16, 2027.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 93 days
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- AMPLICON SEQUENCING SERVICES
US Geological Survey, Ofc of Acquisition Grants-Denver
SolicitationNAICS 541714Location not published140G0226Q0047Closes in 5 daysNov 5 - High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)
Defense Advanced Research Projects Agency, Def Advanced Research Projects Agcy
SolicitationNAICS 541714Anywhere in the USDARPA-PA-27-01Closes in 6 daysNov 5 - Firefox
Defense Advanced Research Projects Agency, Def Advanced Research Projects Agcy
SolicitationNAICS 541714Anywhere in the USDARPA-PS-26-137Closes in 10 daysNov 9
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Cost_Appendix_8_PreawardSurvey_Accounting_System.pdf1.4 MB, October 30, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
October 30, 2026
Special notice
Due January 22, 2027 at 5:00 PM EST. SAM.gov, notice 85dacc8ad6aa4cd59ae08f37a9f63355
2 revisions on SAM
- October 30, 2026: publish, special notice
- October 30, 2026: publish, special notice
October 30, 2026
Special notice
Due February 1, 2027 at 5:00 PM EST. SAM.gov, notice e5782fbc4927487eb38281ad47186a13
2 revisions on SAM
- October 30, 2026: publish, special notice
- October 30, 2026: publish, special notice
Points of contact
- Ian WeissIan.Weiss@fda.hhs.gov3017965728